BCTX
Briacell Therapeutics
BCTX
BCTX
18 hedge funds and large institutions have $12.3M invested in Briacell Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
14% less capital invested
Capital invested by funds: $14.2M → $12.3M (-$1.93M)
Holders
18
Holding in Top 10
1
Calls
$3.2M
Puts
$116K
Top Buyers
| 1 | +$1.45M | |
| 2 | +$231K | |
| 3 | +$60.2K | |
| 4 |
N
Natixis
Paris,
France
|
+$56.3K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$50.9K |
Top Sellers
| 1 | -$546K | |
| 2 | -$361K | |
| 3 | -$308K | |
| 4 |
VF
Virtu Financial
New York
|
-$123K |
| 5 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
-$101K |